To better understand the contribution of signaling triggered by EphB4 and ephrinB2 on tumor growth, we generated HNSCC cells expressing dominant-negative constructs of EphB4 and ephrinB2. Here, EPHB4 is linked to head and neck squamous cell carcinoma.